Relay Therapeutics, Inc. (RLAY)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 7.06 |
| Open | 7.20 |
| Bid | 6.71 x 800 |
| Ask | 6.75 x 700 |
| Day's range | 6.61 - 7.20 |
| 52-week range | 5.70 - 13.32 |
| Volume | |
| Avg. volume | 1,242,952 |
| Market cap | 894.681M |
| Beta (5Y monthly) | 1.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Relay Therapeutics First Quarter 2024 Earnings: Beats Expectations
Relay Therapeutics ( NASDAQ:RLAY ) First Quarter 2024 Results Key Financial Results Revenue: US$10.0m (up by US$9.78m...
- GuruFocus.com
Relay Therapeutics Outperforms Revenue Expectations in Q1 2024
Despite Net Loss, Relay Therapeutics Reports Significant Revenue Growth and Robust Pipeline Progress
- Zacks
Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Tops Revenue Estimates
Relay Therapeutics (RLAY) delivered earnings and revenue surprises of 11.43% and 2,905.11%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.